43,622 Shares in Oscar Health, Inc. (NYSE:OSCR) Bought by Udine Wealth Management Inc.

Udine Wealth Management Inc. bought a new stake in Oscar Health, Inc. (NYSE:OSCR) during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 43,622 shares of the company’s stock, valued at approximately $925,000. Oscar Health makes up 0.7% of Udine Wealth Management Inc.’s investment portfolio, making the stock its 27th biggest position.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Avalon Trust Co purchased a new stake in Oscar Health during the first quarter valued at about $69,000. Point72 Hong Kong Ltd acquired a new position in shares of Oscar Health during the 2nd quarter worth $78,000. Quest Partners LLC bought a new stake in shares of Oscar Health during the 2nd quarter worth $93,000. Amalgamated Bank boosted its holdings in shares of Oscar Health by 27.7% during the 2nd quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock worth $106,000 after buying an additional 1,458 shares during the period. Finally, Farallon Capital Management LLC bought a new stake in Oscar Health in the 1st quarter valued at $164,000. Institutional investors and hedge funds own 75.70% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently commented on the stock. UBS Group started coverage on shares of Oscar Health in a report on Monday. They set a “neutral” rating and a $23.00 price objective for the company. Piper Sandler reiterated an “overweight” rating and set a $28.00 price target on shares of Oscar Health in a research report on Tuesday, September 10th. Finally, Wells Fargo & Company lifted their price objective on shares of Oscar Health from $24.00 to $27.00 and gave the stock an “overweight” rating in a research note on Wednesday, June 12th. Three research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $24.00.

Oscar Health Stock Performance

NYSE:OSCR opened at $18.28 on Wednesday. The company has a market capitalization of $4.34 billion, a PE ratio of -45.70, a P/E/G ratio of 40.11 and a beta of 1.62. Oscar Health, Inc. has a fifty-two week low of $4.72 and a fifty-two week high of $23.79. The company has a 50 day simple moving average of $19.00 and a two-hundred day simple moving average of $18.13. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.91 and a current ratio of 0.91.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings data on Wednesday, August 7th. The company reported $0.20 earnings per share for the quarter, beating the consensus estimate of $0.16 by $0.04. Oscar Health had a return on equity of 1.86% and a net margin of 0.25%. The business had revenue of $2.20 billion for the quarter, compared to analysts’ expectations of $2.13 billion. During the same period last year, the business earned ($0.07) EPS. The business’s revenue was up 44.6% on a year-over-year basis. Research analysts anticipate that Oscar Health, Inc. will post 0.01 earnings per share for the current year.

Insider Buying and Selling

In other news, insider Mario Schlosser sold 3,198 shares of Oscar Health stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total transaction of $57,532.02. Following the completion of the sale, the insider now owns 76,982 shares in the company, valued at approximately $1,384,906.18. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other Oscar Health news, CAO Victoria Baltrus sold 4,226 shares of the firm’s stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total value of $76,025.74. Following the transaction, the chief accounting officer now directly owns 140,648 shares of the company’s stock, valued at approximately $2,530,257.52. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Mario Schlosser sold 3,198 shares of the firm’s stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total value of $57,532.02. Following the completion of the transaction, the insider now directly owns 76,982 shares in the company, valued at $1,384,906.18. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 169,569 shares of company stock valued at $3,007,069. 25.11% of the stock is owned by insiders.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.